Related Experiment Video
Updated: May 29, 2026
10:29
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Molecular modeling approach to predict a binding mode for the complex methotrexate-carboxypeptidase G2
Kely Medeiros Turra1, Kerly Fernanda Mesquita Pasqualoto, Elizabeth Igne Ferreira
1Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of São Paulo- USP, São Paulo, SP, Brazil.
Journal of Molecular Modeling
|August 26, 2011
Summary
Carboxypeptidase G(2) (CPG(2)) research reveals how methotrexate (MTX) binds to the enzyme's active site. This study provides insights into CPG(2)'s catalytic mechanism for cancer therapy and drug detoxification.
Area of Science:
- Biochemistry
- Enzymology
- Computational Chemistry
Background:
- Carboxypeptidase G(2) (CPG(2)) is a zinc-metalloenzyme crucial for cancer chemotherapy, activating prodrugs and treating methotrexate (MTX) intoxication.
- CPG(2) catalyzes the removal of glutamate moieties from folic acid analogs, but its catalytic mechanism remains undetermined.
- No co-crystallized complex of CPG(2) with its substrates has been previously published.
Purpose of the Study:
- To investigate the binding mode of methotrexate (MTX), a known substrate of CPG(2).
- To elucidate the potential catalytic mechanism of CPG(2) through computational modeling.
- To understand the molecular interactions within the CPG(2) active site.
Main Methods:
- Molecular docking simulations were employed to predict the binding pose of MTX within the CPG(2) active site.
- Short molecular dynamics (MD) simulations were conducted at varying temperatures to assess binding stability.
- Analysis focused on identifying key interactions and conformational changes relevant to catalysis.
Main Results:
- MTX was found to bind specifically within the CPG(2) active site, suggesting a precise molecular recognition mechanism.
- The pteridine moiety of MTX fits into a pocket adjacent to the active site, while the glutamate moiety is oriented towards the protein surface.
- A potential interaction between a glutamate residue and a catalytic water molecule was identified, supporting its role in nucleophilic attack.
Conclusions:
- The study proposes a specific binding mode for MTX in the CPG(2) active site, offering insights into the enzyme's substrate recognition.
- The findings suggest a plausible catalytic mechanism involving a glutamate residue and a water molecule, crucial for understanding CPG(2) function.
- This computational approach provides a foundation for further experimental studies on CPG(2) mechanism and drug design.
Related Concept Videos
01:16Protein-Drug Binding: Mechanism and Kinetics
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
02:18The Equilibrium Binding Constant and Binding Strength
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
02:40Ligand Binding Sites
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
01:17Phase II Reactions: Methylation Reactions
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
02:00Molecular Models
Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.
01:19Allosteric Proteins-ATCase
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...